Lawmakers from both parties are criticizing a proposed Medicare policy, saying it could discourage medical innovation and make it harder for patients to access newer cancer treatments.
The proposal is tied to a Biden-era drug pricing law that gave Medicare authority to negotiate certain drug prices.
